Home ›
Trademark Categories ›
Pharmaceuticals ›
2022 ›
LY ›
LYOTHRIVE
Trademark search for:
LYOTHRIVE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2022-11-22 — Application filed
2022-11-25 — Application filed
2022-11-25 — Application filed
2023-09-05 — Assigned to examiner
2023-09-18 — Approved for pub - principal register
2023-10-04 — Notification of notice of publication e-mailed
2023-10-24 — Published for opposition
2023-10-24 — Official gazette publication confirmation e-mailed
2023-12-19 — Noa e-mailed - sou required from applicant
2024-06-20 — Sou teas extension received
2024-06-20 — Notice of approval of extension request e-mailed
2024-06-20 — Sou extension 1 filed
2024-06-20 — Sou extension 1 granted
2024-12-19 — Sou extension 2 filed
2025-01-09 — Teas petition to revive received
2025-01-09 — Petition to revive-granted
2025-01-09 — Notice of revival - e-mailed
2025-01-09 — Sou extension received with teas petition
2025-01-22 — Assigned to examiner
2025-03-17 — Case assigned to intent to use paralegal
2025-03-19 — Sou extension 2 granted
2025-03-20 — Notice of approval of extension request e-mailed
2025-07-21 — Application abandoned
2025-07-21 — Application abandoned
2025-07-21 — Final status recorded
Owner Information
Vivex Biologics Group, Inc.
Atlanta , GA
Vivex Biologics Group, Inc.
Atlanta , GA
Correspondent
Devonte King DAVID L. KING,SR, LLC 5131 NE COUNTY ROAD 340 HIGH SPRINGS, FL 32643 United States
Filing Details
Filing Date:
2022-11-22
Status Date:
2025-07-21
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.